← All organizations

Highest phase reached
Phase 2
First clinical trial
Aug 1, 2016Last known activity
Aug 6, 2018
Timeline
2010s
- Jan 1, 2014
Shanghai Cell Therapy Research Institute— Founded
Drugs by trial phase (8 distinct, 9 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT03615313Lead sponsorPhase 1/Phase 2Aug 6, 2018
- NCT03615313Study directorPhase 1/Phase 2Aug 6, 2018
- NCT03615313Study chairPhase 1/Phase 2Aug 6, 2018
- NCT03179007Study chairPhase 1/Phase 2Jun 7, 2017
- NCT03179007Study directorPhase 1/Phase 2Jun 7, 2017
- NCT03179007Lead sponsorPhase 1/Phase 2Jun 7, 2017
- NCT03182816Study directorPhase 1/Phase 2Jun 7, 2017
- NCT03182816Study chairPhase 1/Phase 2Jun 7, 2017
- NCT03182803Study directorPhase 1/Phase 2Jun 7, 2017
- NCT03182803Study chairPhase 1/Phase 2Jun 7, 2017
- NCT03182803Lead sponsorPhase 1/Phase 2Jun 7, 2017
- NCT03182816Lead sponsorPhase 1/Phase 2Jun 7, 2017
- NCT03347097CollaboratorEarly Phase 1Jan 1, 2017
- NCT02873520Study chairPhase 1/Phase 2Aug 1, 2016
- NCT02873416Study chairPhase 1/Phase 2Aug 1, 2016
Details
- Founded
- Shanghai, CN Jan 1, 2014
- Last known activity
- Aug 6, 2018